Secondary Malignancies After Allogeneic Stem-Cell Transplantation in the Era of Reduced-Intensity Conditioning; The Incidence Is Not Reduced

被引:0
|
作者
Shimoni, Avichai [1 ]
Shem-Tov, Noga [1 ]
Volchek, Yulia [1 ]
Yerushalmi, Ronit [1 ]
Nagler, Arnon [1 ,2 ]
机构
[1] Chaim Sheba Med Ctr, Div Hematol, IL-52621 Tel Hashomer, Israel
[2] Tel Aviv Univ, Guy Weinshtock Multiple Myeloma Fdn, Tel Hashomer, Israel
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:299 / 300
页数:2
相关论文
共 50 条
  • [1] Secondary malignancies after allogeneic stem-cell transplantation in the era of reduced-intensity conditioning; the incidence is not reduced
    Shimoni, A.
    Shem-Tov, N.
    Chetrit, A.
    Volchek, Y.
    Tallis, E.
    Avigdor, A.
    Sadetzki, S.
    Yerushalmi, R.
    Nagler, A.
    LEUKEMIA, 2013, 27 (04) : 829 - 835
  • [2] Secondary malignancies after allogeneic stem-cell transplantation in the era of reduced-intensity conditioning; the incidence is not reduced
    A Shimoni
    N Shem-Tov
    A Chetrit
    Y Volchek
    E Tallis
    A Avigdor
    S Sadetzki
    R Yerushalmi
    A Nagler
    Leukemia, 2013, 27 : 829 - 835
  • [3] Second Malignancies after Allogeneic Stem Cell Transplantation with Reduced-Intensity Conditioning: Is the Incidence Reduced?
    Shimoni, Avichai
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (11) : 1669 - 1670
  • [4] Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: The incidence is not reduced
    Shimoni, A
    Yeshurun, M
    Hardan, I
    Avigdor, A
    Ben-Bassat, I
    Nagler, AN
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (07) : 484 - 493
  • [5] Thrombotic microangiopathy following allogeneic stem-cell transplantation in the era of reduced-intensity conditioning: The incidence is not reduced.
    Shimoni, A
    Yeshurun, M
    Hardan, L
    Avigdor, A
    Papatryphonos, A
    Tsolakis, FI
    Nagler, A
    BLOOD, 2003, 102 (11) : 466A - 466A
  • [6] Allogeneic stem cell transplantation after reduced-intensity conditioning in lymphoid malignancies
    A. Sureda
    N. Schmitz
    Annals of Hematology, 2003, 82 : 1 - 13
  • [7] Allogeneic stem cell transplantation after reduced-intensity conditioning in lymphoid malignancies
    Sureda, A
    Schmitz, N
    ANNALS OF HEMATOLOGY, 2003, 82 (01) : 1 - 13
  • [8] Thrombotic microangiopathy (TMA) following allogeneic stem-cell transplantation (SCT) in the era of reduced-intensity conditioning: The incidence is not reduced
    Shimoni, A
    Hardan, I
    Yeshurun, M
    Avigdor, A
    Papatryphonos, A
    Tsolakis, FI
    Nagler, A
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 68 - 68
  • [9] A comparison of nonmyeloablative and reduced-intensity conditioning for allogeneic stem-cell transplantation
    Le Blanc, K
    Remberger, M
    Uzunel, M
    Mansson, J
    Barkholt, L
    Ringdén, O
    TRANSPLANTATION, 2004, 78 (07) : 1014 - 1020
  • [10] Secondary malignancies after allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning and outpatient conduction
    Zamora-Ortiz, Gabriela
    Velazquez-Sanchez-de-Cima, Sara
    Ponce-de-Leon, Sergio
    Homero Gutierrez-Aguirre, Cesar
    Jose Ruiz-Delgado, Guillermo
    Gomez-Almaguer, David
    Jose Ruiz-Argueelles, Guillermo
    HEMATOLOGY, 2014, 19 (08) : 435 - 440